Stay updated on Subcutaneous CDX-0159 Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous CDX-0159 Clinical Trial page.

Latest updates to the Subcutaneous CDX-0159 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page shows a non-user-facing revision update (v3.4.1 to v3.4.2) with no changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedFooter revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedShow glossary is added, and there are minor metadata/versioning updates (Last Update Submitted that Met QC Criteria, No FEAR Act data wording, and Revision: v3.4.0).SummaryDifference0.3%

- Check41 days agoChange DetectedRevision: v3.3.4 was applied, replacing v3.3.3. Other page content, including study details, eligibility criteria, and endpoints, appears unchanged.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded a Locations section with a Nebraska site (Lincoln, Nebraska). Removed the prior Nebraska Locations content and the HHS Vulnerability Disclosure link; updated revision to v3.3.3.SummaryDifference0.3%

- Check92 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page footer, signifying a small site update.SummaryDifference0.1%

Stay in the know with updates to Subcutaneous CDX-0159 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous CDX-0159 Clinical Trial page.